Marine Drugs (May 2022)

Recent Advances in the Heterologous Expression of Biosynthetic Gene Clusters for Marine Natural Products

  • Yushan Xu,
  • Xinhua Du,
  • Xionghui Yu,
  • Qian Jiang,
  • Kaiwen Zheng,
  • Jinzhong Xu,
  • Pinmei Wang

DOI
https://doi.org/10.3390/md20060341
Journal volume & issue
Vol. 20, no. 6
p. 341

Abstract

Read online

Marine natural products (MNPs) are an important source of biologically active metabolites, particularly for therapeutic agent development after terrestrial plants and nonmarine microorganisms. Sequencing technologies have revealed that the number of biosynthetic gene clusters (BGCs) in marine microorganisms and the marine environment is much higher than expected. Unfortunately, the majority of them are silent or only weakly expressed under traditional laboratory culture conditions. Furthermore, the large proportion of marine microorganisms are either uncultivable or cannot be genetically manipulated. Efficient heterologous expression systems can activate cryptic BGCs and increase target compound yield, allowing researchers to explore more unknown MNPs. When developing heterologous expression of MNPs, it is critical to consider heterologous host selection as well as genetic manipulations for BGCs. In this review, we summarize current progress on the heterologous expression of MNPs as a reference for future research.

Keywords